TCRT
Alaunos Therapeutics Inc (TCRT)
Healthcare • NASDAQ • $2.58-3.26%
- Symbol
- TCRT
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $2.58
- Daily Change
- -3.26%
- Market Cap
- $6.20M
- Trailing P/E
- N/A
- Forward P/E
- -4.30
- 52W High
- $6.20
- 52W Low
- $1.67
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- -1.13
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. The company develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. It also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Company websiteResearch TCRT on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.